Lee H.g.
42
Coauthors
6
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2009 | 1 |
2011 | 2 |
2012 | 1 |
2016 | 1 |
2019 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Neurología | 5 |
Neuropsicología | 5 |
Biología celular | 1 |
Biología molecular | 1 |
Fisiología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Fisiología humana | 6 |
Enfermedades | 5 |
Fisiología y materias afines | 2 |
Farmacología y terapéutica | 2 |
Mammalia | 1 |
Ginecología, obstetricia, pediatría, geriatría | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 6 |
Google Scholar | 0 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Pallás M. | 6 |
Antoni Camins | 6 |
Casadesús G. | 6 |
Smith M.A. | 4 |
Zhu X. | 3 |
Grizzanti J. | 2 |
Perry G. | 2 |
Ortuo-Sahagún D. | 1 |
Gutiérrez-Cuesta J. | 1 |
Tajes M. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease
ReviewAbstract: Aging leads to a number of physiological alterations, specifically changes in circulating hormone lePalabras claves:Alzheimer disease, amylin, DIABÉTES, Insulin, leptin, obesityAutores:Antoni Camins, Casadesús G., Grizzanti J., Lee H.g., Pallás M.Fuentes:scopusThe sirtuin pathway in ageing and Alzheimer disease: Mechanistic and therapeutic considerations
OtherAbstract: Background: Advances in gerontology have yielded crucial insights into the molecular and biochemicalPalabras claves:Autores:Antoni Camins, Bonda D.J., Casadesús G., Lee H.g., Pallás M., Smith M.A., Zhu X.Fuentes:scopusNeuronal cell cycle re-entry markers are altered in the senescence accelerated mouse P8 (SAMP8)
ArticleAbstract: Senescence-accelerated mice 8 (SAMP8), a model of aging, display many established pathological featuPalabras claves:aging, Alzheimer's disease, CDK5, cell cycle, GSK3β, TauAutores:Antoni Camins, Casadesús G., Gutiérrez-Cuesta J., Jiménez A., Lee H.g., Ortuo-Sahagún D., Pallás M., Smith M.A., Tajes M.Fuentes:scopusNeuroprotective effects of the amylin analog, pramlintide, on Alzheimer's disease are associated with oxidative stress regulation mechanisms
ArticleAbstract: Administration of the recombinant analog of the pancreatic amyloid amylin, Pramlintide, has shown thPalabras claves:Alzheimer's disease, amylin, metabolism, neuroprotection, Oxidative Stress, pramlintideAutores:Antoni Camins, Blair J., Casadesús G., Corrigan R., Grizzanti J., Lee H.g., Mey M., Pallás M., Patrick S.Fuentes:scopusUnveiling "the switch" from aging to Alzheimer's disease with the senescence-accelerated mouse model (SAMP8)
ReviewAbstract: Current mouse models of Alzheimer's disease (AD) are restricted to the expression of AD-related pathPalabras claves:aging, Alzheimer's disease, Amyloid-β, Animal models, COGNITION, Gliosis, Neurodegeneration, Oxidative Stress, SAMP8, Tau phosphorylationAutores:Antoni Camins, Casadesús G., Chang J., Kim H.J., Lee H.g., Pallás M., Perry G., Smith M.A., Zhu X.Fuentes:scopus